Soluble RAGE Prevents Type 1 Diabetes Expanding Functional Regulatory T Cells

Type 1 diabetes is an autoimmune disease with no cure, where clinical translation of promising therapeutics has been hampered by the reproducibility crisis. Here, short-term administration of an antagonist to the receptor for advanced glycation end products (sRAGE) protected against murine diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, Sherman S., Borg, Danielle J., McCarthy, Domenica A., Boursalian, Tamar E., Cracraft, Justen, Zhuang, Aowen, Fotheringham, Amelia K., Flemming, Nicole, Watkins, Thomas, Miles, John J., Groop, Per-Henrik, Scheijen, Jean L., Schalkwijk, Casper G., Steptoe, Raymond J., Radford, Kristen J., Knip, Mikael, Forbes, Josephine M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Diabetes Association 2022
Materias:
Pathophysiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862506/
https://www.ncbi.nlm.nih.gov/pubmed/35713929
http://dx.doi.org/10.2337/db22-0177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9862506/
https://www.ncbi.nlm.nih.gov/pubmed/35713929
http://dx.doi.org/10.2337/db22-0177

Ejemplares similares